Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source
Ambient air temperature and out-of-hospital cardiac arrest: A national case-crossover study. [PDF]
Yamron E +8 more
europepmc +1 more source
ABSTRACT Background Despite recommendations in international guidelines, Intracoronary pressure wire assessment (PWA) utilization remains limited in clinical practice. This study aims to describe (i) trends of PWA during Percutaneous coronary interventional (PCI), (ii) factors that predict its application, and (iii) association with in‐hospital ...
Hussein Bashar +3 more
wiley +1 more source
Two patients with out‐of‐hospital cardiac arrest
Julian Hupf +2 more
doaj +1 more source
Artificial intelligence applications in out-of-hospital cardiac arrest: an analysis of emerging research trends. [PDF]
Fee S, Nichols E, Ganti L, Banerjee P.
europepmc +1 more source
Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures
ABSTRACT Background Recent studies have questioned whether iodinated contrast is causally related to acute kidney injury (AKI). AIM We pursed a contemporary analysis to determine the impact of contrast dose on AKI following coronary procedures in an era of lower contrast doses and less nephrotoxic agents.
Harshita Gaba +6 more
wiley +1 more source
The ICECAP Study Did Not Find Evidence for Better Outcomes With Prolonged Cooling After Out-Of-Hospital Cardiac Arrest. [PDF]
Aneman A, Nielsen N, Skrifvars MB.
europepmc +1 more source
Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease
ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton +3 more
wiley +1 more source
Racial and ethnic differences in time to shock delivery in out-of-hospital cardiac arrest. [PDF]
Shimabukuro A +17 more
europepmc +1 more source
Pain is a key determinant of quality‐of‐life following breast cancer surgery, the most common cancer operation in the United States. Gabapentinoids are frequently prescribed for pain management, yet their respiratory, cardiovascular, and opioid‐related adverse effects remain unclear.
Jyun‐Heng Lai +12 more
wiley +1 more source

